ArticleFrontiers in immunology2021

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.

David Pires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.